GBT

Global Blood Therapeutics, Inc. Common Stock

$62.85 +$0.20 +0.32%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$62.85
Total Return$7.83
Range Today$61.38 - $63.60
52 Week Range$24.02 - $68.05
Open$63.55
Market Cap$2.73B
Volume/Average244.18K/1.06M
P/E Ratio-
Dividend/Yield-




Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.


Wallet Positions

Buy Date Buy Price Quote Return $ Return % Owners

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-11-08 19:34 17-11-15 22:26 $38.99 $41.00 +$2.01 +5.14% xvpulsevx mistacat
17-11-08 19:37 17-11-15 22:24 $38.99 $41.00 +$2.01 +5.14% xvpulsevx
17-11-08 19:38 17-11-15 22:25 $38.99 $41.00 +$2.01 +5.14% xvpulsevx
17-12-15 18:39 17-12-21 18:52 $36.50 $38.41 +$1.91 +5.22% coffeeworld
17-11-08 19:31 17-11-08 19:35 $38.99 $38.90 -$0.09 -0.24% xvpulsevx